In the BioHarmony Drug Report Database
Alupent (metaproterenol) is a small molecule pharmaceutical. Metaproterenol was first approved as Alupent on 1982-01-01. It is used to treat asthma, bronchial spasm, chronic bronchitis, and pulmonary emphysema in the USA. The pharmaceutical is active against beta-2 adrenergic receptor.
Image (chem structure or protein)